ACMR was recently featured on The Weekly Check-Up with Dr. Bruce Feinberg on WSB-AM 750 and 95.5 FM. Chief Executive Officer, Eric Riesenberg, Controller, Chuck DeMars, and Project Manager, Megan Shulman sat down with host Dr. Feinberg on the August 12th show.
Founded in 1982 by Dr. Robert A. Riesenberg, ACMR is one of the largest independent clinical research centers in the country and draws participants from all over the Southeast. In 2014, ACMR relocated to a 150,000-square-foot, state-of-the-art, open-source research facility in the Southwest Atlanta area, the former Southwest Atlanta Hospital. The new location has been a driving force in the revitalization of the Southwest, Atlanta neighborhood surrounding the new facility.
On the show, the ACMR team shared how this new facility allows ACMR to offer four divisions of clinical research: central nervous system (CNS), vaccination, medical, and devices. It also allows ACMR to offer their participants a patient-focused experience, assisting in addressing any barriers of participating in the trials. The team discussed how this transition enhanced not only ACMR’s capabilities but offered the city of Atlanta a source for multi-specialty clinical research services typically not found in a hospital or university setting.
Riesenberg, DeMars, and Shulman discussed some of the many benefits of participating in a clinical study, which included possible diagnosis of certain conditions, access to cutting edge medicines, no insurance needed, no out of pocked expenses, and potential compensation for participants’ time. The ACMR team also emphasized the importance of the safety precautions and measurements in place for the research conducted at their facility. Most of the medications being tested have already been tested in other humans. Often, these clinical trials are being held in efforts to cut side effects and improve treatment methods for certain diseases and conditions. Participants could potentially be accessing improvements on existing medications.
The ACMR team shared with the audience that there was a great variety in the types of conditions being held at the center such as Alzheimer’s disease, Parkinson’s disease, schizophrenia, depression, mood disorders, and many more. Currently, ACMR’s vaccination division is working on a C. difficile study. This vaccination offers the elderly community the opportunity to a possible safeguard from contracting this potentially life-threatening condition after an extended stay in a medical center. Shulman also shared another interesting study being conducted at ACMR for adolescent postpartum depression. She discussed how the facility offers flexibility and resources for participants and their caregivers for this trial.
Listen to the full show at: https://weeklycheckup.com/2018/08/12/eric-riesenberg-and-megan-shulman-of-acmr/